Stay updated with breaking news from John Wallenburg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In The News is a roundup of stories from The Canadian Press designed to kickstart your day. Here is what's on the radar of our editors for the morning of April 21 ... What we are watching in Canada ...
TORONTO - A drug considered the "single greatest innovation in the history of cystic fibrosis" has been approved in Canada for children aged six to 11.
Trikafta was approved for use in Canada last June. In late September, four provincial governments — Quebec, Ontario, Saskatchewan and Alberta — announced they would cover the treatment's hefty price tag of around $300,000. For people like Chelsea Gagnon, that's welcome news.
British Columbia, Alberta, Saskatchewan, Ontario and Quebec have all recently announced they will cover Trikafta — which costs about $300,000 a year — for eligible patients.
TOTTENHAM, ONT. -- It's been a long road for Sasha Haughian, whose two sons live with cystic fibrosis (CF). "I just never thought we would get this far," the Tottenham mom says after receiving news that Health Canada gave the green light to a life-saving new drug to treat CF, called Trikafta. Both her boys, Andre, 11, and Joshua, 9, were diagnosed with CF, a genetic disease that has no cure and affects the digestive system and lungs. CF is a progressive disease that can take a toll. Andre and Joshua live with a chronic cough that can keep them up nights.